Post by
thelordofstocks on Feb 07, 2022 6:52pm
New Opportunity
As a long time NUMI shareholder, I want to point some attention to Origin Therapeutics. They are an actively-managed investment issuer providing investors with a diverse exposure to the psychedelic industry. The psychedelic space is a $100 billion market opportunity and the vast majority of companies created to capture this opportunity are private companies, which means everyday investors are unable to reap the benefits. Check em out!